Series C extension of £4.8M bringing total funding to £18.8M. Round led by returning investors and through the IP Group Hostplus Innovation Fund; new support from an unnamed U.S. investor.
About Brainomix
Oxford-based AI healthtech company developing automated medical imaging platforms (Brainomix 360 Stroke and e-Lung) to support stroke assessment and detect/track pulmonary fibrosis with FDA-cleared products used in over 20 countries.
Oxford, United Kingdom
Read Company ProfileFrequently Asked Questions
What type of funding round did Brainomix raise?
Brainomix raised a series-c round.
How much did Brainomix raise in its series-c?
Brainomix raised $4,800,000 GBP in its series-c.
When did Brainomix raise its series-c?
Brainomix raised its series-c on 2026-02-24.
Who invested in Brainomix's series-c?
The investors in Brainomix's series-c are: IP Group Hostplus Innovation Fund, Returning investors, Unnamed U.S. investor.
What type of investment was Brainomix's series-c?
Brainomix's series-c was a equity investment.
How will Brainomix use the funds from its series-c?
Brainomix plans to use the funds for: expand U.S. presence, improve customer support in U.S. and Europe, accelerate hospital network integration, advance development of stroke and lung imaging platforms.